FEED ENvue Medical, Inc.
Healthcare$1.01+8.60%ClosedMarket Cap: $1.1M
As of 2026-05-25
Valuation
P/E (TTM)
—
PEG
—
P/B
0.10
P/S
0.51
EV/EBITDA
-0.00
DCF Value
$-93.28
FCF Yield
-1117.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
-12.4%
Operating Margin
-623.3%
Net Margin
-744.2%
ROE
-43.7%
ROA
-40.7%
ROIC
-39.2%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $653.0K | -8.4% | $-3.7M | $-3.8M | $— | — |
| Q4 null | $312.0K | -118.6% | $-3.7M | $-12.9M | $— | — |
| FY null | $2.6M | 6.0% | $-11.7M | $-18.2M | $— | — |
| Q3 null | $722.0K | 26.2% | $-2.2M | $600.0K | $— | — |
| Q2 null | $494.0K | -7.1% | $-4.0M | $-156.0K | $— | — |
| Q1 null | $1.0M | 36.0% | $-1.9M | $-2.5M | $— | — |
| Q4 null | $444.0K | 63.7% | $-1.4M | $-1.4M | $— | — |
| FY null | $2.6M | 59.0% | $-3.6M | $-3.7M | $— | — |
| Q3 null | $376.0K | 35.4% | $-970.0K | $-998.0K | $— | — |
| Q2 null | $817.0K | 52.4% | $-674.0K | $-688.0K | $— | — |
| Q1 null | $921.0K | 72.1% | $-568.0K | $-588.0K | $— | — |
| Q4 2023 | $1.2M | 62.6% | $-702.0K | $-813.0K | $-43.70 | — |